Part of the guide: MLM Reviews: The Honest Index
A few years back a company called iLearningGlobal closed its network marketing division, and in one afternoon my entire online business went to zero. Not down. Zero. Every dollar of it ran through that one company, and when they flipped a switch, my income flipped with it. I tell you that up front because this Elomir review is really a story about the same risk wearing a different costume. Elomir launched in 2022 selling a yellow strip that dissolves on your tongue, promised the world, drew regulators, and then quietly went dark. If you typed “elomir review” into Google because someone pitched you, or because you already joined and you are nervous, you are asking the right question at the right time. Let me give you the honest version.
I have been in and around this industry since 2002. I have built teams, lost teams, reviewed dozens of companies, and watched people get rich and go broke inside the exact same opportunity in the exact same month. So I am not here to dunk on Elomir for sport. I am here to walk you through what the public record actually shows, what the product really is at the molecular level, how the money was structured, and the one lesson that matters whether you ever touch this company or not.
In this guide
- What Elomir actually is (and who is really behind it)
- The Axis Klärity strip: what is in it, and the dosage problem
- The compensation plan, in plain numbers
- The honest concerns this Elomir review has to name
- Who actually wins in a company like Elomir
- The due-diligence playbook: how to vet any opportunity before you join
- The Elomir review verdict (2026)
What Elomir actually is (and who is really behind it)
Elomir is a Texas-based direct-selling company. The public story is that it was founded by a husband-and-wife team, Toan and Van Nguyen, and launched to the field in July 2022. The incorporation paperwork tells a slightly different story. The entity was registered on September 9, 2021, and corporate records list Terry LaCore as the director. LaCore runs a stable of MLM brands under LaCore Enterprises, so Elomir was never a scrappy garage startup. It was a new product dropped into an existing MLM machine.
That matters for one reason: when a “founder story” and the legal filing do not match, you have learned something before you have spent a dollar. You have learned the marketing and the paperwork are two different documents. The Nguyens themselves had real history in the space, with time at LegalShield, Nerium, and World Global Network. Toan had also been promoting a string of crypto programs on YouTube. None of that is illegal, but all of it is the kind of thing you want to know before your name and your reputation are attached.
The Axis Klärity strip: what is in it, and the dosage problem
Elomir sold essentially one product: Axis Klärity. It is a dissolvable strip, berry flavored, sweetened with stevia, that you place on your tongue. A box of 30 strips retailed for $89, which works out to about $2.97 a day. The pitch leaned on “diffusion technology,” the idea that letting the active ingredients absorb sublingually gets them into you faster than a capsule that has to survive your stomach.
Here is the part most reviews skip, and it is the part a careful reader should care about. The strip has three active ingredients: a curcumin conjugate (from turmeric), an NAC conjugate (N-acetylcysteine), and a thiamine conjugate (vitamin B1). The sublingual delivery idea is real science. Plenty of compounds do absorb well under the tongue. But the total active blend was around 45mg.
Sit with that number. In the published research people point to, curcumin is typically studied at 500mg to 2,000mg per day. NAC studies routinely run 600mg to 1,800mg. The dose that makes a strip taste fine and absorb fast is a tiny fraction of the dose the studies actually used. The industry self-regulator flagged exactly this: the animal studies and ingredient research being cited did not match the 45mg proprietary blend in the product. So even if you grant that sublingual delivery is more efficient, you still have a real gap between “here is a study on this ingredient” and “here is what is in this strip.” That is not a scam claim. It is a measurement.
Then there is NAC itself. The U.S. FDA has taken the position that N-acetylcysteine is a drug ingredient, because it was approved as a drug decades before it showed up in supplements. That makes selling it in a dietary supplement legally murky in the United States. The FDA has signaled enforcement discretion at times, and NAC is sold freely in places like Canada, but “the regulator says this ingredient may not belong in a supplement here” is a structural risk that sits underneath the whole product. So the strip working is the smaller question. The bigger one is whether its main ingredient is even legal to sell here at all.
The compensation plan, in plain numbers
Educated buyers want the mechanics, so here they are without the hype. To participate as an affiliate you paid a $49 annual fee, which was waived if you bought the $250 Enrollment Pak (that pak included three boxes of product). From there the money moved in a few ways:
- Retail commission: 35% on the volume of customer orders. Selling the actual strips to actual customers was the cleanest way to earn.
- Recruitment / fast-start: a weekly commission, reported around 15% on the volume tied to the $250 Enrollment Pak, plus fast-start tiers.
- Residual unilevel: a monthly commission paying down a capped number of levels (reported around four levels, roughly 5% per level, scaling with rank).
- Ranks and bonuses: roughly 15 ranks from Brand Partner up to Legend, with rank-achievement bonuses that the company materials described climbing into five and six figures.
Read that structure again. The 35% retail line is healthy and points toward selling product. But a meaningful chunk of the early, fast money was tied to the $250 Enrollment Pak, meaning to recruiting people who buy in, not to customers who reorder because the strip changed their life. That is the design tension in a lot of MLMs, and it is the thing regulators watch most closely. It is not proof of anything by itself. It is the dial you check first.
The honest concerns this Elomir review has to name
This is where I have to be fair to you instead of comfortable. The documented record on Elomir is not light.
The watchdog TINA.org compiled more than 75 health and disease-treatment claims being made for the product, including claims around anxiety, depression, inflammation, diabetes, viral infection, and even autism. Those are drug claims. You cannot make them for a supplement without FDA approval, and Elomir did not have it. On the money side, leaders were reportedly touting commissions in “multiple seven figures” within the company’s first month, alongside distributor talk of paying off mortgages and funding retirement.
What the self-regulator actually found
That drew a formal look. The Direct Selling Self-Regulatory Council opened Case #139-2023 and closed it on November 29, 2023. The council found the health claims unsubstantiated and the income claims atypical, and it recommended Elomir discontinue them until the company could show reliable data on what a typical distributor actually earns. Elomir said it would cooperate and comply. Worth being precise here: the DSSRC is an industry self-regulation body, not a court and not the FTC. This was not a fraud ruling. It was a documented finding that the advertising went past what the evidence supported.
On the operational side, the launch was rough. Orders went unfulfilled because demand outran inventory, the money was collected anyway, and refunds were hard to come by. A later product launch reportedly flopped the same way. And then the quiet ending: by mid-2025 the company’s website was returning a 404, and as of this writing the domain no longer resolves to an Elomir storefront at all. For practical purposes, the company appears defunct.
So the real answer to “is Axis Klärity a good opportunity in 2026” is almost anticlimactic. There does not appear to be a live company to join. Which is exactly the point I lost an entire business learning.
If a company can change the rules, withhold your pay, or disappear overnight, your income was never really yours. See how a public smart contract pays 100% commissions you can read on-chain in about 12 seconds.
Show me a comp plan I can actually verify →Most participants earn little to nothing. No income is guaranteed. You can verify every payout on the public smart contract.
Who actually wins in a company like Elomir
In any opportunity like this, three kinds of people show up. The first kind buys product because they genuinely like it, never recruits, and treats the $89 as a personal purchase. If the strip helped them, they got their money’s worth and they are fine. The second kind gets in early, can actually sell and lead, and rides the launch wave. A few of them did well for a while. The third kind is the largest by far: people who joined on the income story, recruited a handful of friends, and then watched fulfillment problems and regulatory heat and finally a dead website take it all back down to zero.
Here is the uncomfortable truth the high earner needs to hear. The person in group two, the one who can sell and lead, would have done fine in almost any company. The skills traveled. The company was the rental car, not the engine. My friend Aaron Rashkin once had 5,000 active people in one of the largest juice companies in the world and was making about $4,000 a month, because the model, not his effort, was capped. Same effort under a model built for scale is a different number entirely. The lesson repeats no matter the brand on the door: your ability to generate attention, enroll people, and build a team is the asset. The company is a wrapper around it.
The due-diligence playbook: how to vet any opportunity before you join
Since there is no live Elomir to build, let me give you the thing that is actually worth more than this one review: the exact checklist I run when choosing the right MLM company, before I let my name touch any program. Do this and you will never get caught the way I got caught with iLearningGlobal, or the way the late joiners got caught here.
- Check the ingredient law and the dose, not the brochure. Look up each active ingredient’s regulatory status (NAC would have failed this in five minutes), then compare the amount in the product to the amount in the studies they cite. A 45mg blend against 600mg studies tells you what you are really buying.
- Demand the income disclosure statement. Every honest opportunity can show you what a typical participant earns. If there is no published disclosure and the only numbers are stage stories about seven figures, treat your expected income as zero and decide from there.
- Read the incorporation records, not the founder video. Who is the actual director? When was it really formed? When the legal filing and the origin story disagree, believe the filing.
- Search the regulators and watchdogs by name. Run the company against the FTC, your state attorney general, the DSSRC, and TINA.org. I ran this same exercise publicly years ago when readers asked about the Numis Network and the FTC. A single case decision is not a death sentence, but you want to read it yourself before you recruit your sister.
- Test fulfillment with one small order before you recruit a soul. Buy one box. See if it ships, how fast, and how returns work. The people who recruited first and ordered later were the ones holding the bag.
- Never let one company be your only rail. This is the iLearningGlobal scar talking. Build authority that you own, a list you control, and skills that transfer, so no single company’s bad day becomes your bankruptcy.
- Own the part that survives. The audience, the email list, the selling skill, the system. Those outlive every company you will ever promote. If you are starting from scratch, my recommended products and tools page is where I keep the short list of what I actually use to build the part nobody can take away.
The Elomir review verdict (2026)
Calling Elomir a “scam” would be lazy and, frankly, legally sloppy, because there was a real product, a real company, and no fraud conviction. What the record supports is narrower and more useful: a single-product MLM, built on an ingredient with an unresolved legal status, marketed with health and income claims a self-regulator told them to stop making, with fulfillment problems at launch, that now appears to be out of business. Compare that record with a wellness company like Melaleuca, which has operated for decades, and you see why longevity you can verify is its own due-diligence signal. If someone is still trying to recruit you into Elomir in 2026, that alone should end the conversation.
But you did not really come here to bury one yellow strip. You came because you are evaluating whether opportunities like this can build the life you want. And that is the part worth your attention.
Now for the part that actually matters: whether a company like Elomir works for you has almost nothing to do with the company. I have watched people get rich and go broke inside the same comp plan in the same month. The variable was never the strip or the percentages. It was whether they had a way to generate leads, enroll people, and build a team that did not depend on a company staying alive and honest on their behalf. That is a system. Leaders use systems. And the most painful failure in a company like this is not the product. It is that you cannot verify anything. You cannot audit the inventory, the income claims, the ingredient science, or the company’s solvency, until the day your own order does not arrive.
That is the exact problem the system I use was built to solve. Instead of trusting a private dashboard that can be rewritten, the commissions run through a public smart contract that pays 100% the same block as the sale, in about 12 seconds, readable by anyone on the blockchain. Nobody can quietly skim it, change it, or make it disappear. The contract is the truth. The first time you watch a payment you can actually verify land in your wallet, something in your chest unclenches. You stop refreshing a dashboard and praying the number holds. You stop bracing for the afternoon a stranger flips a switch on your livelihood. That is the real prize, bigger than any single check: the quiet certainty that the thing you are building cannot be taken from your family because someone you never met had a bad quarter. After what I lost when one company flipped a switch, that is the only kind of income I am willing to build on now.
Stop betting your income on a company you cannot audit. See how the on-chain system I use pays 100% commissions you can verify yourself, then build the one asset no company can take back: your own skill and your own list.
See the system I use →Most participants earn little to nothing. No income is guaranteed. You can verify every payout on the public smart contract.
Disclosure and disclaimer: This is an independent third-party review based on publicly available information as of June 2026, and details may change. I am not affiliated with Elomir. Some links in my offers are affiliate links to programs I personally use. Network marketing and affiliate income vary widely; most participants earn little to nothing, and no income is guaranteed. Nothing here is medical advice. Always do your own due diligence.
Sources and further reading
- BehindMLM: Elomir review and compensation plan breakdown
- TINA.org: What You Should Know About Elomir
- DSSRC Case #139-2023: Elomir, Inc.
- The Daily Beast: coverage of Elomir’s health claims
See also: the tools and systems I actually recommend, and start here if you’re new to building income online.
Three posts a day. One email a day.
Everything I publish, in one short daily email. Real numbers, no hype, unsubscribe in one click.
The three-way breakdown near the end is the most honest part of this. Everyone wants to talk about the leader who rode the launch wave, but the review’s own math says the third group, the ones who joined on the income story, was the largest by far. That’s the case worth discussing, not the exception. Rare and impossible aren’t the same thing, and this piece actually says so.
Hector’s median-case point reminds me of something with bike suppliers, actually. Every few years a component maker gets bought out, promises the earth to shops like mine, and two years later the parts stop showing up and nobody explains why. Same shape as this: a founder story that doesn’t match who’s actually listed on the paperwork, health claims stacked past what the ingredient can support, then a quiet vanishing act. The Terry LaCore detail is the tell for me, a ‘new’ company registered a year before its own launch story, under a guy who runs a stable of these things. You don’t need to understand curcumin dosing to smell that one. You just need to read who signed the incorporation papers.
Declan, the bit about the rental car not being the engine, that’s the whole review in one line. Good catch.
The checklist assumes the reader’s plan is to join and recruit under someone else’s company. There’s another option: never join anything, and just own the audience.
Look. The ‘skills traveled, company was the rental car’ line is doing a lot of work here. Convenient framing if you want to say the model was never the problem. Fine, the ingredient dose is the actual smoking gun, not the skill of whoever sold it. Read the number, forty-five milligrams against studies using ten to twenty times that, and tell me which one of those needed a decade of sales training to spot.
Sorry if this is a dumb question, but does that mean the strip might have actually done something, just not what they were claiming, or was even the small dose basically doing nothing at all? I ask because I was looking at something similar for my own health, not to sell, just to take, and now I genuinely don’t know what to think.
Small correction: the FDA’s position on NAC isn’t murky, it’s fairly settled that it’s excluded from the dietary supplement definition, what’s uncertain is enforcement, not the legal status. That distinction matters if you’re trying to gauge actual risk. Everything else here checks out against the DSSRC case number, which is more than most reviews bother to verify.
Priya, thank you for this correction. I ask because it concerns my own situation. In Turkey we do not have anything similar to the DSSRC or the FDA overseeing supplement ingredient claims from outside companies. If a company like this already has compliance trouble in its home market, is that more risk for a market where nobody is checking at all, or less, since nobody notices either way?